Reference : Le pimecrolimus (Elidel) hors des sentiers battus.
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/8897
Le pimecrolimus (Elidel) hors des sentiers battus.
French
[en] Pimecrolimus (Elidel) for a variety of skin diseases.
Hermanns-Lê, Trinh mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Hermanns, Jean-François mailto [Université de Liège - ULg > Département des sciences cliniques > Dermatopathologie >]
Thirion, Laurence [CHU > > Dermatologie > >]
Pierard, Claudine [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
2006
Revue Médicale de Liège
61
4
256-9
Yes (verified by ORBi)
0370-629X
Belgium
[en] Dermatologic Agents/therapeutic use ; Humans ; Skin Diseases/drug therapy ; Tacrolimus/analogs & derivatives/therapeutic use
[en] Pimecrolimus is an immune downregulator that belongs to the class of calcineurin inhibitors. Its efficacy is recognized for the topical treatment of the mild to moderate types of atopic dermatitis. In addition, the drug shows activity in a series of other dermatitides. We report a review of the international literature about this topic.
http://hdl.handle.net/2268/8897

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
PIMECROLIMUS.pdfNo commentaryPublisher postprint433.86 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.